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problems: a multitude of definitions of cognitive
decline are used, and a large number of neuropsycho-
logic tests exist to assess the various cognitive
domains.6 Moreover, the interval between operation and
administration of the neuropsychologic tests may range
from a few days to several years. Some literature
reviews on cognitive deficits after CPB have been pub-
lished,7-10 but the methodologic variability of the stud-
ies hampers comparison of the results. 
At a consensus meeting in 1994, several guidelines
for the assessment of neuropsychologic deficits after
CPB were established.11 It was recommended that the
neurologic and neuropsychologic state be assessed
before the operation to provide accurate baseline infor-
mation. A second important recommendation was that
the analysis should be based on the individual change in
performance from baseline to a particular time after the
operation. In general, practice effects cause the overall
group performance to improve after the operation.
Accordingly, when the overall postoperative mean is
compared with the preoperative mean, the decline of
Coronary artery bypass grafting (CABG) with the useof cardiopulmonary bypass (CPB) is associated with
significant cerebral morbidity.1 The two main clinical
manifestations of brain injury after CABG are stroke
and cognitive decline.1 The incidence of postoperative
stroke is consistently reported to be around 3%1,2 and as
high as 9% in patients older than 75 years.3,4 However,
the reported incidence of cognitive decline varies wide-
ly.5 This variability is partly caused by methodologic
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some individuals is overshadowed by the improvement
of others. Also, it was agreed that a late assessment
(ideally after 3 months) should be included in the study
design, because the patients’ performances are unstable
in the immediate postoperative period.
Although these consensus guidelines were developed
for the design of new research protocols, we found
some of them also suitable to interpret studies carried
out in the past. This systematic review is restricted to
studies on cognitive decline 1 to 12 months after
CABG, which were considered methodologically
homogeneous according to well-defined and strict cri-
teria. Both the primary selection of studies and the
assessment and comparison of the studies that were
included were largely based on recommendations of
the 1994 consensus.11 As a result of the technical
improvements of CPB and the alterations in anesthetic
management, studies published before 1980 were con-
sidered less relevant and therefore were excluded.
Methods
Literature search. For the literature search, four electron-
ic databases (MEDLINE, PsychLit, PubMed, and Current
Contents) and references of four earlier published (abstract)
books and three reviews were used. The precise search strat-
egy is described in Table I. To assess the quality of the search
strategy, we sampled ten studies that we already had on file
and considered relevant. The search strategy was able to iden-
tify these articles. The total number of different titles found
was 256 (Table I).
Selection of the literature. The studies were independent-
ly judged by a clinician and a psychologist using the follow-
ing selection criteria:
Inclusion criteria:
• Primary research on cognitive decline after CABG,
including a preoperative neuropsychologic assessment
to provide baseline information
• Postoperative neuropsychologic assessment between 1
and 12 months after the operation
• Data analysis based on the individual change in perfor-
mance from baseline to a time after the operation
Exclusion criteria:
• Studies published before 1980
• Studies including open chamber or valvular procedures
• Studies with unclear timing of test administration
• Articles describing the same or an overlapping patient
sample as other articles already included in the review
These selection criteria were applied on the 256 titles
found. Thirty-four articles could be excluded on the basis of
the title only and 111 articles were excluded on the basis of
the abstract. For the remaining 111 titles, the complete article
was studied. The majority of these publications were written
in English. Many articles were excluded because data of
patients undergoing CABG were mixed with data of patients
having valve replacement, because data analysis was based
on comparison of mean group performance before and after
the operation, or because only an early postoperative neu-
ropsychologic assessment (ie, less than 1 month) was per-
formed. Seven studies were excluded14-20 because the same
patient series had (partly) been used in other studies already
included in the review and their inclusion would have
overemphasized the results of these series. Finally, one arti-
cle published in Japanese was rejected because a translation
could not be obtained. Only 23 articles matched all the selec-
tion criteria.5,21-42
Literature processing. The 23 articles meeting the selection
criteria were processed independently by a psychologist and
a clinician using a three-page standard form. This form was
filled out to systematically assess the research question, study
design, neuropsychologic tests used, statistics, main conclu-
sions, and other items. The forms were the basis for Tables II
and III in the “Results” section. 
The neuropsychologic sections were independently judged
by two trained neuropsychologists, blinded for author and
journal names. Again, several recommendations of the
Statement of Consensus11 were taken into account.
Table I.  Literature search: Sources and results
Source No. of titles found
• MEDLINE electronic database 1980-1999: Medical Subject Heading (MeSH) standard terms: (heart surgery or coronary 
artery bypass or extracorporeal circulation or cardiopulmonary bypass; cognition disorders) and (cognitive symptoms or
neuropsychology or neuropsychological tests)
• PsychLit electronic database 1980-1999: standard terms: (heart surgery) and (neuropsychological assessment or cognitive 
assessment or cognition or concentration or attention)
• Book: “Cardiac Surgery and the Brain” by Smith and Taylor12: relevant references of relevant chapters
• Abstract books of the conferences on cardiac surgery and the brain: “Outcomes—The Key West Meeting,” ‘97, ‘98, ‘99:
relevant references of relevant chapters
• The references of three recent reviews on cardiac surgery and cognitive decline9,10,13
• Current Contents and PubMed 1999: January–September
• Total number of different titles
In the numbers of titles found, articles published before 1980 and books are not included.
161
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67
69
91
18
256
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Neuropsychologic test batteries were rated with respect to (1)
the cognitive domain of the tests, (2) the sensitivity of the
tests, (3) the availability of parallel forms of the tests, and (4)
the overall balance of the cognitive domains assessed in the
battery. So that the comparability of the studies could be fur-
ther improved, (5) a recommended core battery was taken as
the basis for our assessment of quality of the test batteries
used. This core battery minimally includes the Rey Auditory
Verbal Learning Task, the Trail Making Tests A and B, and
the Grooved Pegboard. These tests are widely used, easy to
conduct, well-normalized, and sensitive to cerebral damage. 
Analysis. Studies were classified as (1) cohort studies,
aiming to determine the incidence of cognitive decline at a
certain moment after the operation and/or to identify deter-
minants of cognitive decline, or (2) intervention (controlled)
studies, investigating the cerebral protective effect of intraop-
erative interventions.
To determine whether a pooled analysis could be carried
out, we assessed the comparability of the studies entered into
the review in terms of precise timing of neuropsychologic
testing, comparability of tests, and definition of decline.
Results
Cohort studies. The twelve cohort studies meeting
the selection criteria are presented in Table II. Some of
these studies exclusively aimed to determine the inci-
dence of neuropsychologic decline, whereas others
were designed to identify determinants of cognitive
decline. The studies in Table II are ordered by year of
publication. The mean age of the patients studied
increased over time, but no clear time trend could be
observed in the incidences of cognitive deficits, which
varied from 4% to 47%.
None of the studies designed as a correlation
study21,25,26,28,31 was able to identify determinants of
cognitive decline in the primary analysis. However, in
a multivariate analysis, Tardiff and associates26 found a
significant association between short-term memory
dysfunction after CABG and a variant form of the
apolipoprotein E gene, especially in patients with lower
educational levels. This gene encodes the APOE pro-
tein, which is responsible for repair of neuronal injury
and probably involved in the development of
Alzheimer disease.
Intervention studies. The eleven intervention studies
included are shown in Table III. Ten of them were ran-
domized trials. In two studies, the initial data analysis
demonstrated that the intervention studied led to a sta-
tistically significantly (P < .05) decreased risk of cogni-
tive decline. Hammon and colleagues42 compared the
results in patients operated on in 1991 and 1992 with
results in patients operated on in the next 2 years. In the
second time period, the surgical team had adopted the
use of epiaortic scanning and had increased the use of
the single crossclamp technique and left ventricular
venting. This combined strategy reduced the incidence
of cognitive decline by 11% (P = .01). The other study
Table II.  Cohort studies
Definition Proportion 
Mean NP-test Lost to No. of of of patients
First Year of No. of age timing follow-up tests cognitive with cognitive
author publication patients (y) (mo) (%) used deficit Comparability deficit (%)
Ellis21 1980 30 55 1 0 3 7 – 17
Shaw22 1987 259 54 6 17 10 2 – 22
Treasure23 1989 76 55 2 12 10 2 ++ 37
Harrison24 1989 78 55 2 40 10 2 ++ 36
Mahanna5 1996 232 61 1.5/6 60/61 5 7* – 14*/4*
Toner25 1996 61 60 2 0 10 2 ++ 38
Tardiff26 1997 65 62 1.5 12 7 6 – 47
McKhann27 1997 172 63 1/12 26 8 4 + †
Braekken28 1998 14 64 2 0 10 2 + 14
Vanninen29 1998 38 64 3 3 8 3 – 22
Browne30 1999 120 ? 3 0 2 7‡ – ‡
Rasmussen31 1999 35 70 3 17 5 7 – 14
NP-test timing, Time between CABG and postoperative neuropsychologic test administration; Definition of cognitive deficit: 1 (≥1 SD in ≥1 test); 2 (≥1 SD in ≥2
tests); 3 (≥1 SD in ≥3 tests); 4 (≥ 0.5 SD in a domain); 5 (≥20% in ≥2 tests); 6 (≥20% in ≥20%); 7 (other); Comparability: ++, tests of “core battery” are used (Rey
Auditory Verbal Learning Task, Trail Making Tests A and B, Grooved Pegboard); +, comparable tests were used; –, tests were not comparable with core battery.
*Five different definitions were used. The percentages given are for 1 SD decline in one or more tests.
†Analyzed per domain.
‡Three different definitions were used on two tests. Proportions of patients with deficit varied from 7% to 33%.
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with a significant result in the initial analysis showed a
beneficial effect of the use of an arterial line filter.35
Many intervention studies had insufficient statistical
power to detect clinically meaningful differences. In
some of these studies, post hoc use of another defini-
tion of cognitive decline led to significant results. One
example is the remacemide trial by Arrowsmith and
coworkers.33 Individual cognitive decline was less fre-
quent in the treated group, but the study lacked power
to reach statistical significance. Redefining cognitive
decline as “overall postoperative change” made the
favorable effect of remacemide statistically significant.
Pulsatile blood flow during CPB did not improve
neurocognitive outcome in 316 patients,36 but in the
same series, alpha-stat blood gas management reduced
the incidence of cognitive deficits. This reduction was
significant in patients with a bypass time of more than
90 minutes. The protective effect of alpha-stat blood
gas management was also found by Patel and associ-
ates.37 The observed difference became statistically sig-
nificant when a more stringent definition of neuropsy-
chologic deficit (decline on three tests instead of two
tests) was used.
The three studies on the influence of perfusion tem-
perature39-41 failed to demonstrate a clear advantage of
hypothermia compared with normothermia, but the
sample sizes of the studies were relatively small, and in
the study of Heyer and colleagues41 only 26% of the
study patients were available for follow-up.
Neuropsychology. The selected studies included
neuropsychologic tests as the measure of cognitive
decline. Of the 23 selected studies, six included the
core battery as recommended by the Statement of
Consensus.11 In addition, four studies used tests sim-
ilar to the recommended core battery (see Tables II
and III). Accordingly, ten studies were at least par-
tially comparable and met with widely accepted qual-
ity criteria.
Four study groups5,22,30,37 used several definitions of
cognitive decline in their samples. The definition used
most frequently (in nine studies) was a postoperative
deterioration of at least 1 standard deviation (of the
population’s performance at baseline) compared with
preoperative testing in at least two tests. In one study
the same definition was used with a minimum of three
tests showing deterioration, whereas one other study
took deterioration in one test as criterion. Com-
parability in terms of definition of cognitive decline
was thus limited to nine studies.
Pooled analysis. Four cohort studies23-25,28 and two
intervention studies33,35 were comparable not only in
definition of decline and use of the core battery or com-
parable tests, but also in timing of test administration.
These six studies in total included 505 patients, of
whom 448 completed 2 months of follow-up (Table
IV). We combined the results of these studies in a
weighted average (the sum of the proportions of
patients with cognitive decline per study times number
of patients per study, divided by the total number of
patients). For the two intervention studies, the weight-
ed mean of the two treatment groups was used. On
average, 22.5% of the CABG patients had a decline of
at least 1 standard deviation in at least two of a total of
nine or ten tests 2 months after their operation 
(P < .0001; 95% confidence interval, 18.7%-26.4%).
Discussion
This study systematically reviewed reports on cogni-
tive decline after CABG. The literature search was
extensive. In an attempt to select studies that could be
compared, we formulated stringent selection criteria. A
limitation of using these selection criteria is that some
informative aspects of research were rejected. The rel-
atively small number of the studies that could be
included in the review underlines the lack of compara-
bility of studies carried out until now.
The reported incidences of cognitive deficits varied
widely. At least in part, this can be explained by the dif-
ferences in timing of test administration and definitions
of cognitive deficit. A high loss to follow-up in 3 stud-
ies5,24,41 may also have influenced the incidences found,
as loss to follow-up is seldom random.6 Most of the
included studies were comparable in terms of neuropsy-
chologic tests used, which is probably encouraged by the
Statement of Consensus that was held in 1994.11
Within the six studies used for the pooled analysis,
there was still a considerable variation in the reported
incidence of cognitive decline (10%-38% 2 months
after the operation). It is not possible to conclude from
these studies that the incidence of cognitive deficits has
decreased in the past 10 years. Improved outcome as a
result of better anesthesiologic and perfusion manage-
ment may be offset by the increasing age of the
patients, which in itself is associated with an increased
risk for cerebral complications.36,42 With the six select-
ed studies, we calculated an average incidence of cog-
nitive deficits of 22.5% 2 months after CABG. This fig-
ure must be interpreted with caution because, even
within these six studies, methodologic differences were
present. For example, the cutoff value of 1 standard
deviation, used to define a deficit, varied per study,
because the baseline performances of the six patient
series are inevitably not the same. A formal meta-
analysis, which is typically performed with a series of
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Cardiovascular Surgery
October 2000
methodologically comparable randomized trials,
includes the use of more advanced weighing factors,
testing of homogeneity of the effect estimates of the
different studies, and a sensitivity analysis. However,
the methodology of meta-analysis of uncontrolled
observational studies is subject to debate,43 and its use
in this review would have unjustly suggested a high
level of objectiveness and precision.
The clinical meaning of a decline of 1 standard devia-
tion in two tests is relative, because the figure calculated,
22.5%, does not indicate the percentage of patients who
are significantly disabled after CABG. Several authors
emphasize that, in most patients, the deficit does not mat-
ter to the patient in functional terms. Apparently, many
activities of daily life do not require the level of perfor-
mance called for during neuropsychologic testing.
Table III.  Intervention studies
First Year of No. of Mean NP-test Lost to No. of 
author publication patients age (y) timing (mo) follow-up (%) tests used
Fish32 1987 2 × 50 58 2 26 10
Arrowsmith33 1998 87 + 84 59 2 7 9
Sellman34 1993 3 × 20 59 1/6 10 13
Pugsley35 1994 53 + 52 55 2 5 10
Murkin36 1995 4 × 79 61 2 24 5
Patel37 1996 2 × 35 57 1.5 0 10
Gold38 1995 2 × 124 66 6 9 11
Mora39 1996 54 + 55 63 1.5 23 5
Regragui40 1996 31 + 36 + 29 59 1.5 27 7
Heyer41 1997 46 + 53 64 1.5 74 5
Hammon42 1997 192 + 203 61 1.5 ? 11
NP-test timing, Time between CABG and postoperative neuropsychologic test administration; Definition of cognitive deficit: 1 (≥1 SD in ≥1 test); 2 (≥1 SD in ≥2
tests); 3 (≥1 SD in ≥3 tests); 4 (≥0.5 SD in a domain); 5 (≥20% in ≥2 tests); 6 (≥20% in ≥20%); 7 (other); Comparability: ++, tests of “core battery” are used (Rey
Auditory Verbal Learning Task, Trail Making Tests A and B, Grooved Pegboard); +, comparable tests were used; –, tests were not comparable with core battery.
Table IV.  The four cohort studies and two intervention studies that were comparable
Mean NP-test No. of No. of patients Proportion of 
First Year of No. of age timing tests who completed patients with 
author publication patients (y) (mo) used follow-up cognitive deficit (%)
Treasure23 1989 76 55 2 10 67 37
Harrison24 1989 78 55 2 10 47 36
Pugsley35* 1994 105 55 2 10 100 17.45*
Toner25 1996 61 60 2 10 61 38
Arrowsmith33* 1998 171 59 2 9 159 10.45*
Braekken28 1998 14 64 2 10 14 14
Total 505 448
Weighted average 22.5
The four cohort studies and two intervention studies that were comparable in definition of cognitive decline (a decline in performance at least 1 standard deviation
in at least two tests), use of the core battery (Rey Auditory Verbal Learning Task, the Trail Making Tests A and B, and the Grooved Pegboard) or comparable neu-
ropsychologic tests, and timing of test administration (2 months after operation). These six studies include 505 patients, of whom 448 completed 2 months of follow-
up. To calculate a weighted average, the proportion of patients with cognitive decline per study was multiplied with the number of patients per study who complet-
ed follow-up. The sum of the multiplications was then divided by the total number of patients who completed follow-up. On average, the proportion of patients with
cognitive decline was 22.5% (P < .0001; 95% confidence interval, 18.7%-26.4%).
* Intervention studies, in which the weighted mean of the proportions of patients with a deficit in the two treatment groups was used.
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However, a small proportion of patients with intellectual
dysfunction or memory deficits become sufficiently dis-
abled to prevent return to employment.1,22
The discrepancy between decline in test performance
and functional decline is also expressed by the method-
ologic difficulties of defining a cognitive deficit.
Mahanna and colleagues5 demonstrated the enormous
influence of the definition of cognitive deficit that is
chosen by applying five different definitions on the
same patient sample. Depending on the definition used,
the incidence of cognitive deficit ranged from 1.1% to
34% at 6 weeks and from 3.4% to 19.4% at 6 months
postoperatively.
Most authors defined deficit as a certain deterioration in
one or more tests, which may seem accurate. However,
some tests comprise more than one test variable, and
from most studies it was not clear whether test deficit
meant deterioration in one or all of the variables of one
test. This obviously creates a multitude of possible out-
comes and is therefore a factor complicating the interpre-
tation of the incidence data. A deterioration of 1 standard
deviation in postoperative functioning compared with
preoperative functioning was the most frequently used
cutoff value. This is arbitrary and does not necessarily
reveal real cognitive change, since it does not take into
account the reliability of the change scores. Practice
effects were almost always mentioned but not included in
analyses, which may have resulted in an underestimation
of incidence figures. There is emerging recognition of the
importance of defining real change in test-retest scores as
opposed to artifactual change resulting from low test reli-
ability and susceptibility to practice effects. Recent
research is increasingly focused on the use of reliable
change indices. These indices define the range in which
an individual score is likely to fluctuate because of the
imprecision of the measure, providing statistically based
cutoff scores for cognitive change on each measure.44,45
For example, a 90% reliable change interval is calculated
on the basis of the correlation and the standard error of
the difference between baseline and follow-up scores of
control subjects. When the difference between an indi-
vidual patient’s postoperative and preoperative scores
falls outside this interval, he or she is considered to have
a statistically significant change in performance on this
particular neuropsychologic measure.44
The single-case analysis technique, recommended in
the consensus statements,11,46 uses the patient as his or
her own control and defines a cognitive deficit as a
20% decrease in at least 20% of the tests. This method
also has some drawbacks. In the first place, reducing
the continuous test scores to a dichotomous outcome
measure (presence of a 20% decrease or not) is a “cost-
ly” way of data handling that reduces statistical power
and may have made several randomized studies fail to
Definition of
cognitive deficit Comparability Intervention studied Results
7 – Prostacyclin during CPB 0% cognitive decline in intervention group and control group
2 + Remacemide vs placebo Remacemide group: 9% decline; placebo group: 12% decline 
(P = .6)
2 – Membrane vs bubble oxygenator and Bubble ox, no filter: 24%/12% decline; bubble ox, with filter:
use of arterial line filter 12%/6%  decline; membrane ox, no filter:
15%/5% decline. All differences NS
2 ++ Use of arterial filter Filter group: 8.2% decline; control group: 26.7% decline (P < .03)
7 – Alpha-stat vs pH-stat blood gas Alpha-stat group: 30% cognitive dysfunction;
management and pulsatile vs nonpulsatile pH-stat group: 36% cognitive dysfunction 
CPB (NS); pulsatility has no effect on outcome
2 ++ Alpha-stat vs pH-stat blood gas Alpha-stat group: 45.7% np deficit;
management pH-stat group: 68.6% np deficit (NS)
7 – Blood pressure during CPB: 50-60 mm Low pressure group: 12% deteriorated;
Hg vs 80-100 mm Hg high pressure group: 11% deteriorated (NS)
1 – Perfusion temperature <28°C vs >35°C 15% deterioration in both treatment groups
7 – Perfusion temperature 28°C vs 32°C Significantly more deterioration in 37°C group than compared
vs 37°C to 32°C group (P = .015)
7 + Perfusion temperature 28°C vs 34°C 15% decline in 28°C group; 39% decline in 34°C group; 
difference  NS
5 ++ Combination of epiaortic scanning, Intervention group: 18% decline; standard treatment group:
more use of single crossclamp and more 29% decline  (P = .01) (nonrandomized study)
ventricular venting vs standard treatment
reach statistically significant results. The 20% decrease
rule is as arbitrary as the 1 standard deviation decrease
rule. The problem may be overcome by refraining from
“dichotomizing” data and just calculating how much
the patient’s performance deviates from the expected
(baseline or control group) performance. Second, due
to floor effects it may be difficult to demonstrate a
deficit in patients with a low preoperative test perfor-
mance. In the third place, as demonstrated by Browne
and colleagues,30 “regression toward the mean” may
strongly influence single-case definitions of cognitive
deterioration. High baseline performers may be wrong-
ly classified as impaired and low baseline performers
may not show a deficit although deterioration had actu-
ally occurred. This problem can be overcome by using
group mean analysis, which is free from the influence
of regression to the mean (in contrast to analysis by sin-
gle-case definitions). As discussed before, comparison
of mean group performance before and after surgery
does have disadvantages, especially if large practice
effects are present. However, if a suitable control group
is available (randomized trial), comparison of group
means allows for the control of both practice effects
and regression to the mean.
Conclusions
A pooled analysis of six highly comparable studies
yielded a proportion of 22.5% of patients with a cogni-
tive deficit 2 months after CABG. Although this per-
centage is partly determined by the definition of cogni-
tive deficit that was used, it demonstrates that cognitive
dysfunction is a frequently occurring complication of
CABG. The etiologic contribution of CPB to this com-
plication will remain unclear until a randomized trial
that directly compares off-pump CABG with on-pump
CABG is carried out. To improve comparability of
future studies, we advocate that researchers use the
guidelines of the 1994 consensus meeting. However,
the recommended single-case analysis technique has
some drawbacks and may be replaced by other analysis
techniques, especially when a control group is included
in the study design.
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